Key result
OVLT neuron activation elevates sympathetic nerve activity and blood pressure via ganglionic transmission.
Why the study?
The extent to which organum vasculosum of the lamina terminalis (OVLT) neurons directly regulate sympathetic nerve activity to produce hypertension was unknown.
Does acute optogenetic and chronic chemogenetic activation of OVLT neurons increase sympathetic nerve activity to produce hypertension in Sprague-Dawley rats?
Does acute optogenetic and chronic chemogenetic activation of OVLT neurons increase sympathetic nerve activity to produce hypertension in Sprague-Dawley rats?
Demonstrates in a preclinical rat model that acute and chronic activation of OVLT neurons directly drives sympathetic nerve activity via RVLM premotor neurons to produce neurogenic hypertension independent of vasopressin or fluid intake.
Answers are grounded in this paper and cite their sources.
OVLT neuron activation drives sympathetic hypertension in rats; leaves open translation to human neurogenic mechanisms.
Neurons in the organum vasculosum of the lamina terminalis (OVLT) sense extracellular NaCl and angiotensin II concentrations to regulate body fluid homeostasis and arterial blood pressure. Lesion of the anteroventral third ventricular region or OVLT attenuates multiple forms of neurogenic hypertension. However, the extent by which OVLT neurons directly regulate sympathetic nerve activity to produce hypertension is not known. Therefore, the present study tested this hypothesis by using a multi-faceted approach including optogenetics, single-unit and multifiber nerve recordings, and chemogenetics. First, optogenetic activation of OVLT neurons in conscious Sprague-Dawley rats (250-400 g) produced frequency-dependent increases in arterial blood pressure and heart rate. These responses were not altered by the vasopressin receptor antagonist (β-mercapto-β,β-cyclopentamethylenepropionyl1,O-me-Tyr2,Arg8)-vasopressin but eliminated by the ganglionic blocker chlorisondamine. Second, optogenetic activation of OVLT neurons significantly elevated renal, splanchnic, and lumbar sympathetic nerve activity. Third, single-unit recordings revealed optogenetic activation of the OVLT significantly increased the discharge of bulbospinal, sympathetic neurons in the rostral ventrolateral medulla. Lastly, chronic chemogenetic activation of OVLT neurons for 7 days significantly increased 24-hour fluid intake and mean arterial blood pressure. When the 24-hour fluid intake was clamped at baseline intakes, chemogenetic activation of OVLT neurons still produced a similar increase in arterial blood pressure. Neurogenic pressor activity assessed by the ganglionic blocker chlorisondamine was greater at 7 days of OVLT activation versus baseline. Collectively, these findings indicate that acute or chronic activation of OVLT neurons produces a sympathetically mediated hypertension.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied Sympathetically mediated hypertension (experimental rat model). Optogenetic and chemogenetic activation of OVLT neurons (rAAV9-CaMKIIa-hChR2(H134R)-mCherry with 473nm light or rAAV9-hSYN-HA-hM3D(Gq)-IRES-mCherry with clozapine-N-oxide) vs. Control rats with viral expression outside the OVLT or no expression (OVLT-o / OVLT-x), or pretreatment with saline, vasopressin receptor antagonist, or ganglionic blocker (chlorisondamine/hexamethonium) was evaluated on Arterial blood pressure (mean ABP) and sympathetic nerve activity (renal, splanchnic, and lumbar SNA) (p=<0.05). Acute optogenetic and 7-day chronic chemogenetic activation of OVLT neurons increased sympathetic nerve activity and arterial blood pressure, an effect eliminated by ganglionic blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: